• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Eclipse Aesthetics

7 medtech stories we missed this week: April 28, 2017

April 28, 2017 By Danielle Kirsh

From FDA and Health Canada approvals to joint ventures, here are 7 medtech stories we missed this week but thought were still worth mentioning. 1. FDA clears Joimax Endovapor 2 Joimax announced in an April 26 press release that it has received FDA 510(k) clearance to market its Endovapor 2 Multi-Radio Frequency System. The device […]

Filed Under: Food & Drug Administration (FDA), News Well, Surgical Tagged With: Anaconda Biomed, Creganna Medical, Eclipse Aesthetics, Joimax, Mederi Therapeutics, MedTech, Millennium Medical Technologies, SiBone, Theraclion

FDA warns Eclipse Aesthetics on MicroPen personal dermabrasion device

May 20, 2016 By Fink Densford

The FDA recently released a warning letter it sent to Eclipse Aesthetics, claiming the company lacks appropriate regulatory clearance for its Eclipse Micropen Elite, which it describes as a “dermal micro-needling device” used for skincare applications. The letter came after an FDA inspection in August last year uncovered that the Eclipse MicroPen Elite did not […]

Filed Under: Cosmetic/Aesthetic, Food & Drug Administration (FDA), Regulatory/Compliance Tagged With: Eclipse Aesthetics

EnteroMedics names ex-Lanx chief Gladney as CEO | Personnel Moves

November 2, 2015 By Brad Perriello

EnteroMedics (NSDQ:ETRM) said it named Dan Gladney, the former chief executive who led Lanx to an acquisition by Biomet, to be its new CEO effective Nov. 16. St. Paul, Minn.-based EnteroMedics said chairman, president & CEO Mark Knudson will become executive chairman when Gladney takes over the corner office until Jan. 1, 2016, when he will […]

Filed Under: Wall Street Beat Tagged With: Anika Therapeutics Inc., BioSig Technologies, Eclipse Aesthetics, EnteroMedics Inc., Escalon Medical Corp., Hansen Medical Inc., LifeImage, MELA Sciences Inc., Personnel Moves, Profound Medical Inc., Repro Med Systems

Syneron settles patent lawsuit against EndyMed

February 25, 2013 By Sony Salzman Leave a Comment

Syneron logo

Syneron Medical (NSDQ:ELOS) dropped a patent infringement lawsuit against EndyMed Medical and its distributor, Eclipse Aesthetics, after EndyMed agreed to stop selling its fractional skin resurfacing products in the U.S.

EndyMed will continue to re-supply electrodes and other maintenance items for the products it has already sold, according to a press release.

Filed Under: Cosmetic/Aesthetic, Legal News, News Well, Patent Infringement Tagged With: Eclipse Aesthetics, EndyMed Medical, Syneron Medical Ltd.

Syneron sues aesthetics duo over skin-tightening technology

October 22, 2012 By MassDevice staff Leave a Comment

Syneron logo

Israel-based maker Syneron Medical (NSDQ:ELOS) sued a pair of rival companies over devices that allegedly infringe on 2 Syneron patents for skin ablation technology.

Syneron claimed that EndyMed Medical and Eclipse Aesthetics infringe on the patents by selling use electrodes to apply ablative energy to the skin.

Filed Under: Cosmetic/Aesthetic, Legal News, News Well, Patent Infringement Tagged With: Eclipse Aesthetics, EndyMed Medical, Syneron Medical Ltd.

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy